Strides Arcolab is currently trading at Rs. 756.45, up by 18.40 points or 2.49% from its previous closing of Rs. 738.05 on the BSE.
The scrip opened at Rs. 737.45 and has touched a high and low of Rs. 765.25 and Rs. 737.45 respectively. So far 38689 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 776.90 on 20-Jun-2012 and a 52 week low of Rs. 276.25 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 765.25 and Rs. 711.10 respectively. The current market cap of the company is Rs. 4425.13 crore.
The promoters holding in the company stood at 28.35% while Institutions and Non-Institutions held 55.55% and 16.11% respectively.
Agila Specialties Pharma Corporation, Canada, which is part of the injectable drug division of Strides Arcolab, a globally renowned generic drug manufacturer, has formed a joint venture (JV) with Jamp Pharma, a Canadian generic drug company, to introduce a variety of quality injectable generic drug in Canada.
This sales and marketing joint venture will operate under the name Agila-jamp Canada Inc in which Agila will hold 70% stake and the remaining 30% by Jamp Pharma. The JV will be headquartered in Boucherville, Quebec.
Agila-jamp will be launching around 40 products in the next 2 years. Many of these products have already been approved by Health Canada and will be immediately launched through local hospital and pharmacists. The existing sales force at Jamp Pharma will be responsible to introduce the entire Agila-Jamp product portfolio.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1517.90 |
Dr. Reddys Lab | 6362.00 |
Cipla | 1478.90 |
Zydus Lifesciences | 1066.95 |
Lupin | 1614.95 |
View more.. |